Outstanding poster prizes:
2017: Ms. Karunarathne. Poster title: Project to improve drug compliance among patients on long-term medication for hypertension in National Hospital- Sri Lanka.
2016: Lucy Ashworth (Atlantis Healthcare, UK) Poster title : A personalised patient support programme for people with Acute Coronary Syndrome (ACS): impact on beliefs, treatment adherence and lifestyle
2015: Imran Sulaiman (Department of Respiratory Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland) Poster title : Inhaler adherence following an exacerbation of COPD
2014: Monique van den Ven (Behavioural Science Institute, Radboud University Nijmegen, Netherlands) Poster title : The role of automatic processes in medication adherence of adolescents with asthma
2013: Milene Fernandes (Institute of Preventive Medicine – Faculty of Medicine – University of Lisbon, Portugal) Poster title : Factors associated with patient non-adherence to antiretroviral therapy among HIV-1 infected adults
2012: Eline Tommelein (Ghent University, Belgium) Poster title : Beliefs about Medicines Questionnaire (BMQ) could be helpful in predicting (non)adherent behavior in patients with COPD
About Jean-Michel Métry PhD (1955-2009)
Jean-Michel Métry was born in Sion, Switzerland in 1955, educated in local schools, and did his pre-doctoral education and research at the Swiss Federal Institute of Technology (ETH) in Zürich, under the direction of the late Professor Max Anliker. Dr. Métry’s first job was at the 3-M Corporation in work on cochlear implants. In 1988 he joined California-based APREX Corporation as Director of APREX’s European division, providing MEMS® monitors to European clinical researchers. When APREX was reorganized and sold to Apria Healthcare Corporation in the mid-1990’s, Dr. Métry and Dr. John Urquhart, co-founder of APREX, formed AARDEX Ltd. in Sion, Switzerland, to provide electronic monitors of prescription drug use in ambulatory medical care to the European clinical research marketplace. In the late 1990’s, AARDEX acquired the assets of APREX from Apria, and Dr. Métry became CEO of AARDEX Ltd., located in Sion, Switzerland In 2002, Dr. Métry and Prof. Urs Meyer, Professor of Pharmacology at University of Basel, published the book entitled “Drug Regimen Compliance: Issues in Clinical Trials and Patient Management” (John Wiley & Sons, Chichester, UK). Dr. Métry had a special interest in patient adherence during phase IV studies, as new, orally-administered drugs came into wide usage. The results of these studies played a leading role in bringing wide attention to objective data on ambulatory patients’ often poor adherence to prescribed medicines in all modes of ambulatory care, irrespective of disease severity or prognosis, plus recognition that variable adherence is the leading source of variance in patients’ responses to prescribed, orallyadministered medicines. Dr. Métry’s untimely death in 2009 ended his successful career as a scientist, biomedical engineer, and entrepreneur. The J-M Métry Lectureship of ESPACOMP is dedicated to his memory and his many contributions to the developing field of adherence research.